Blog

ICIJ’s Campaign to Mislead and Stoke Fear into Patients

The International Consortium of Investigative Journalists (IJIC) recently launched its latest campaign, which purports to investigate medical device safety. The “Implant Files,” however, is no more than a misguided attempt to stoke fear and doubt over the safety of medical devices that have saved and improved the lives of millions of Americans. In fact, while attempting to castigate advances in medicinal technology, the campaign itself recognizes that the data they use to support their coverage “is inconsistent and incomplete.”

Here’s the truth: nearly every American has benefited from the advancements of medical technology innovation in their life, from the NICU, to tools used during routine doctors’ visits, to hearing aids, to advanced surgical equipment, to pacemakers, to intraocular lenses, and replacement joints.

MDMA Statement on the ICIJ Coverage of Medical Devices

WASHINGTON, DC – Mark Leahey, President and CEO of the Medical Device Manufacturers Association (MDMA) issued the following statement today regarding the FDA’s release of their “Plan of Action for Implementation of 510(k) and Science Recommendations:”

“We commend FDA leadership and staff for working with various stakeholders in an open and constructive process to develop consensus proposals that improve patient access to safe and effective therapies.  As more details are provided on specific recommendations, MDMA will submit additional comments to FDA to help make the regulatory process more efficient and effective.

View All Blogs

ABOUT MDMA

The Medical Device Manufacturers Association (MDMA) is a national trade association based in Washington, DC providing educational and advocacy assistance to innovative and entrepreneurial medical technology companies. Since 1992, MDMA has been the voice for medical technology innovation, playing a proactive role in helping to shape policies that impact the ecosystem. This is accomplished by working with key Members of Congress, senior staff at FDA, CMS and other agencies, and through the grassroots support of our members.